Physician profile
Andrea E Kessler
NPI 1205065513
$3,843.96
in general payments reported to CMS, 2019-2025
19 companies · $609 in 2025
The $609 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $793 · 2022: $1,232 · 2023: $519 · 2024: $691 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,819.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,020.54 | 2021-2024 | Freestyle Libre 3 |
| Novo Nordisk INC | $367.42 | 2021-2023 | Rybelsus, Ozempic, Tresiba |
| Xeris Pharmaceuticals, INC. | $275.16 | 2021-2025 | Gvoke Hypopen |
| Dexcom, INC. | $273.54 | 2022-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Lilly USA, LLC | $259.73 | 2022-2024 | Zepbound, Mounjaro |
| Corcept Therapeutics | $254.36 | 2023-2024 | Korlym |
| Insulet Corporation | $243.30 | 2021-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $209.29 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $190.44 | 2021-2023 | Tradjenta |
| Ascendis Pharma Endocrinology INC | $143.45 | 2025 | Yorvipath |
| Sequel Med Tech, LLC | $120.93 | 2025 | Twiist |
| Amgen INC. | $113.66 | 2024 | Tepezza |
| Beta Bionics, INC. | $84.22 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Zealand Pharma US, INC. | $80.79 | 2021 | |
| Medtronic, INC. | $74.33 | 2024 | Minimed 780g |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $48.32 | 2023-2025 | |
| Mannkind Corporation | $35.46 | 2022-2024 | |
| Cequr Corporation | $31.27 | 2024 | Cequr Simplicity |
| Tandem Diabetes Care, INC. | $17.75 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.